Article
Humanized hiPSC Platforms for I/R Injury: Advancing Toward Precision Cardioprotection.
Cardiovascular therapeutics - 1 Jan 2026
Mi Mengyan, Chen Tzu-Yu, Ye Honghua
Abstract excerpt
Myocardial ischemia-reperfusion (I/R) injury remains a major contributor to infarct expansion, adverse remodeling, and heart failure despite timely coronary revascularization. The repeated failure of cardioprotective interventions that were effective in animal models has exposed a persistent translational gap. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and engineered cardiac platforms...
Read the complete abstract on PubMedTopics
- Humans
- Induced Pluripotent Stem Cells
- Myocytes, Cardiac
- Animals
- Myocardial Reperfusion Injury
- Microphysiological Systems
